Download PDF
CC BY-NC-ND 4.0 · Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 2023; 42(02): e176-e180
DOI: 10.1055/s-0042-1748845
Case Report | Relato de Caso

Cerebral Aspergillosis in an Immunocompetent Patient after COVID-19 Infection

Aspergilose Cerebral em Paciente Imunocompetente após Infecção por COVID-19
Laryssa C. Azevedo Almeida 
1   Centre for Neurology and Neurosurgery, Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil
,
Henrique Moura Braga 
1   Centre for Neurology and Neurosurgery, Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil
,
Bruno Silva Costa 
1   Centre for Neurology and Neurosurgery, Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Fungal brain abscesses are an uncommon condition in the immunocompetent population, especially due to the etiologic agent Aspergillus sp. The emerging coronavirus disease 2019 (COVID-19) pandemic brought about neurological manifestations that were previously little known, caused by the direct manifestations of the virus, as well as by the therapy itself, with hospitalization and use of corticosteroids. This manuscript highlights the need for attention in the management of patients with neurological disorders and history of COVID-19 infection. In the current paper, we report the case of a patient without comorbidities who presented multiple brain abscesses caused by Aspergillus fumigatus, after infection by Severe Acute Respiratory Syndrome Coronavírus 2 (SARS-CoV-2).

Resumo

Abscessos cerebrais fúngicos são uma condição incomum na população imunocompetente, especialmente quando provocada pelo agente etiológico Aspergillus sp. A epidemia emergente do novo coronavírus (COVID-19) trouxe acometimentos neurológicos até então pouco conhecidos, ocasionados pelas manifestações diretas do vírus, como também pela própria terapia, com internação e uso de corticoesteróides. Este manuscrito destaca a necessidade de atenção no manejo de pacientes com alterações neurológicas e história de infecção pelo vírus. No presente trabalho, relatamos o caso de um paciente sem comorbidades que apresentava múltiplos abscessos cerebrais causados por Aspergillus fumigatus, após infecção pelo SARS-CoV-2.

Keywords

neuroaspergillosis - brain abscess - COVID-19 - aspergillosis

Palavras-chave

neuroaspergilose - abscesso Encefálico - COVID-19 - aspergilose

Informed Consent

The patient's family consented to the presentation of the case for submission to the journal.




Publication History

Received: 22 December 2021

Accepted: 06 April 2022

Article published online:
07 July 2022

© 2022. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Ellenbogen JR, Waqar M, Cooke RP, Javadpour M. Management of granulomatous cerebral aspergillosis in immunocompetent adult patients: a review. Br J Neurosurg 2016; 30 (03) 280-285
    CrossrefPubMedGoogle Scholar
  • 2 Ma Y, Li W, Ao R. et al. Central nervous system aspergillosis in immunocompetent patients: Case series and literature review. Medicine (Baltimore) 2020; 99 (44) e22911
    CrossrefPubMedGoogle Scholar
  • 3 Ruhnke M, Kofla G, Otto K, Schwartz S. CNS aspergillosis: recognition, diagnosis and management. CNS Drugs 2007; 21 (08) 659-676
    CrossrefPubMedGoogle Scholar
  • 4 Spapen H, Spapen J, Taccone FS. et al; AspICU Study Investigators. Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort. Int J Antimicrob Agents 2014; 43 (02) 165-169
    CrossrefPubMedGoogle Scholar
  • 5 Stevens DA, Melikian GL. Aspergillosis in the ‘nonimmunocompromised’ host. Immunol Invest 2011; 40 (7-8): 751-766
    CrossrefPubMedGoogle Scholar
  • 6 Louati I, Zaouali J, Azzouz O. et al. [Cerebral aspergillosis in immunocompetent patients: three case reports]. Rev Neurol (Paris) 2009; 165 (11) 957-961
    PubMedGoogle Scholar
  • 7 Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 1985; 18 (05) 574-582
    CrossrefPubMedGoogle Scholar
  • 8 Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994; 19 (03) 402-408
    CrossrefPubMedGoogle Scholar
  • 9 Boes B, Bashir R, Boes C, Hahn F, McConnell JR, McComb R. Central nervous system aspergillosis. Analysis of 26 patients. J Neuroimaging 1994; 4 (03) 123-129
    CrossrefPubMedGoogle Scholar
  • 10 Jantunen E, Volin L, Salonen O. et al. Central nervous system aspergillosis in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2003; 31 (03) 191-196
    CrossrefPubMedGoogle Scholar
  • 11 Tattevin P, Jauréguiberry S, Gangneux JP. [Cerebral aspergillosis]. Rev Neurol (Paris) 2004; 160 (5 Pt 1): 597-605
    PubMedGoogle Scholar
  • 12 Beraldo D, Guerra R, Alvarenga V, Crepaldi L. Surgical Treatment Alone of Cerebral Aspergillosis in Immunocompetent Patient. J Neurol Surg A Cent Eur Neurosurg 2016; 77 (05) 452-456
    PubMedGoogle Scholar
  • 13 Marzolf G, Sabou M, Lannes B. et al. Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations. PLoS One 2016; 11 (04) e0152475
    CrossrefPubMedGoogle Scholar
  • 14 Wang RX, Zhang JT, Chen Y, Huang XS, Jia WQ, Yu SY. Cerebral aspergillosis: a retrospective analysis of eight cases. Int J Neurosci 2017; 127 (04) 339-343
    CrossrefPubMedGoogle Scholar
  • 15 Hall WA. Improving outcomes in cerebral aspergillosis. World Neurosurg 2014; 82 (1-2): e139-e140
    CrossrefPubMedGoogle Scholar
  • 16 Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther 2020; 12 (01) 69
    CrossrefPubMedGoogle Scholar
  • 17 Satarker S, Nampoothiri M. Involvement of the nervous system in COVID-19: The bell should toll in the brain. Life Sci 2020; 262: 118568
    CrossrefPubMedGoogle Scholar
  • 18 Gupta V, Singh P, Sukriti K. Fungal brain abscess in a post COVID-19 patient. BMJ Case Rep 2021; 14 (09) e246319
    CrossrefPubMedGoogle Scholar
  • 19 Hakamifard A, Hashemi M, Fakhim H, Aboutalebian S, Hajiahmadi S, Mohammadi R. Fatal disseminated aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus ochraceus. J Mycol Med 2021; 31 (02) 101124
    CrossrefPubMedGoogle Scholar